Showing results (61-70 of 75) with videos related to
Sort By:
Pageof 8
European Urology|August 18, 2019
Mortality and Hospitalization Risk Following Oral Androgen Signaling Inhibitors Among Men with Advanced Prostate Cancer by Pre-existing Cardiovascular ComorbiditiesGrace Lu-Yao, Nikita Nikita, Scott W Keith, et al.Cancers|January 16, 2021
Improved Prognostic Stratification Using Circulating Tumor Cell Clusters in Patients with Metastatic Castration-Resistant Prostate CancerChun Wang, Zhenchao Zhang, Weelic Chong, et al.Journal of the National Cancer Institute|March 8, 2026
Risk of fracture following androgen receptor pathway inhibitors in men with advanced prostate cancerGrace Lu-Yao, Nikita Nikita, Scott W Keith, et al.Journal of Geriatric Oncology|December 6, 2021
International trends in cancer incidence in middle-aged and older adults in 44 countriesSophie Pilleron, Naser Alqurini, Jacques Ferlay, et al.Nature Reviews. Rheumatology|January 26, 2026
Recommendations for the use of CLASI as an outcome measure in cutaneous lupus erythematosus clinical trialsGrace Lu, Tyler Cepica, Catherine Barbey, et al.Cancer Medicine|February 9, 2020
Individual and joint effects of metformin and statins on mortality among patients with high-risk prostate cancerXiang-Lin Tan, Jian-Yu E, Yong Lin, et al.Prostate Cancer and Prostatic Diseases|February 23, 2022
Substantial Gleason reclassification in Black men with national comprehensive cancer network low-risk prostate cancer - A propensity score analysisShivanshu Awasthi, Brandon A Mahal, Jong Y Park, et al.Prostate Cancer and Prostatic Diseases|December 6, 2023
Prostein expression on circulating tumor cells as a prognostic marker in metastatic castration-resistant prostate cancerZhenchao Zhang, Rui Luo, William K Kelly, et al.Cancer Medicine|May 31, 2022
Race-specific prostate cancer outcomes in a cohort of military health care beneficiaries undergoing surgery: 1990-2017Nathan Oehrlein, Samantha A Streicher, Huai-Ching Kuo, et al.Cancer Medicine|May 26, 2022
Race-specific prostate cancer outcomes in a cohort of low and favorable-intermediate risk patients who underwent external beam radiation therapy from 1990 to 2017Sean P Stroup, Audry H Robertson, Kayla C Onofaro, et al.Pageof 8